Carl Zeiss Acquires Bio-Rad's Cell Science Division

By Biotechdaily staff writers
Posted on 15 Jun 2004

In a move that will enlarge its microscopy business, Carl Zeiss (Oberkochen, Germany) has acquired the Cell Science Division (Hemel Hempstead, UK) of Bio-Rad Laboratories, Inc. (Hercules, CA, USA). Terms were not disclosed.

This strategic move is part of the ongoing investment in enhancing the application expertise at Carl Zeiss, according to the company. The acquisition is expected to accelerate future advances in confocal and multiphoton microscope instrumentation with Carl Zeiss as the major driving force in the field.

"Today, Carl Zeiss stands for high-end laser scanning microscopes that are benchmark solutions for advanced applications in 3-D microscopy,” said Dr. Ulrich Simon, head of the microscopy business group at Carl Zeiss. "Joining our forces will strengthen our relationship with Zeiss and Bio-Rad customers, and will allow a considerable additional refinement of both companies' worldwide service and support network.”

Related Links:
Carl Zeiss
Bio-Rad